Last updated: January 14, 2025
Sponsor: PeriPharm
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Mellitus, Type 1
Treatment
observational study
Clinical Study ID
NCT06786130
BOD0250
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Parental caregiver of a child recently diagnosed (<= 2 years) with T1D before studyinclusion;
Age ≥18 ;
Residence in the Canada;
Willingess to complete a 20-minute survey
Ability to read and understand French or English;
Signature of informed consent form (ICF)
Exclusion
Exclusion Criteria:
- Participation in a clinical trial.
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: observational study
Phase:
Study Start date:
January 09, 2025
Estimated Completion Date:
March 31, 2025
Connect with a study center
PROxy Network, an initiative of PeriPharm Inc.
Montreal, Quebec H2Y 2H4
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.